StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.83+0.05 (+6.00%)

Close on Nov 18, 2026Market cap $9.82MP/E –Yield –

CytoMed Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CytoMed Therapeutics's price to book ratio was 1.9× on Nov 11, 2026, against 3.1× a year earlier. Over the last 4 years it ranged from 1.3× to 93.0×, with a median of 3.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×−0.3
2025Dec 31, 20252.2×−2.6
2024Dec 31, 20244.8×−88.2
2023Dec 29, 202393.0×–

More CytoMed Therapeutics figures

See a number that looks wrong?